Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida

Pascal M W Groenen1, Iris A L M van Rooij, Petronella G M Peer

  • 1Department of Epidemiology and Biostatistics, University Medical Center, Nijmegen, The Netherlands.

Insights

Maternal vitamin B12 deficiency is linked to a higher risk of spina bifida in offspring. Lower vitamin B12 levels in mothers significantly increased the likelihood of having a child with this neural tube defect.

Area of Science:

  • Nutritional Neuroscience
  • Developmental Biology
  • Public Health

Background:

  • Spina bifida is a serious neural tube defect with significant public health implications.
  • The role of B vitamins and homocysteine in neural tube defect development is an area of ongoing research.
  • Understanding specific nutrient deficiencies associated with spina bifida is crucial for prevention strategies.

Purpose of the Study:

  • To investigate the association between B vitamins (folate, B6, B12) and homocysteine levels and the risk of spina bifida in offspring.
  • To determine if maternal or child nutrient status differs in cases of spina bifida compared to controls.
  • To identify specific B vitamin deficiencies that may serve as risk factors for spina bifida.

Main Methods:

  • Case-control study involving 45 mothers and children with spina bifida and 83 control mother-child pairs.
  • Measurement of serum and red blood cell folate, serum vitamin B12, whole blood vitamin B6, and plasma homocysteine.
  • Statistical analysis to compare nutrient levels and assess risk associated with low vitamin B12 concentrations.

Main Results:

  • Mothers of children with spina bifida had significantly lower vitamin B12 concentrations (21% lower) compared to control mothers.
  • A maternal vitamin B12 concentration below 185 pmol/L was associated with a 3.5-fold increased risk of spina bifida.
  • No significant differences in folate, vitamin B6, vitamin B12, or homocysteine levels were found in children with spina bifida after age adjustment.

Conclusions:

  • Marginal maternal vitamin B12 status is a significant risk factor for spina bifida in offspring.
  • Vitamin B12, rather than folate, B6, or homocysteine, emerged as a critical factor in this study.
  • Maintaining adequate maternal vitamin B12 levels may be important for preventing spina bifida.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...